Clover Health Investments (CLOV) Short Interest Ratio & Short Volume

Short interest is the volume of Clover Health Investments shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 48,160,000 shares of CLOV short. Learn More on Clover Health Investments' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLOV shares currently have a short interest ratio of 5.0. Learn More on Clover Health Investments's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clover Health Investments: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Clover Health Investments saw a increase in short interest in April. As of April 15th, there was short interest totaling 48,160,000 shares, an increase of 9.5% from the previous total of 43,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Clover Health Investments: Skillz Inc. (15.47%), Bright Health Group, Inc. (1.31%), Alignment Healthcare, Inc. (5.17%), Viemed Healthcare, Inc. (1.18%), Nautilus Biotechnology, Inc. (1.95%), GeneDx Holdings Corp. (6.60%), Lyra Therapeutics, Inc. (0.56%), Procaps Group S.A. (0.03%), Aquestive Therapeutics, Inc. (5.47%), Atea Pharmaceuticals, Inc. (2.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling CLOV is an investing strategy that aims to generate trading profit from Clover Health Investments as its price is falling. CLOV shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Clover Health Investments occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLOV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLOV, twice per month. The most recent reporting period available is April, 15 2024.